UBS AM’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.5M | Buy |
86,378
+15,158
| +21% | +$614K | ﹤0.01% | 1883 |
|
|
2025
Q1 | $3.66M | Buy |
71,220
+1,394
| +2% | +$71.6K | ﹤0.01% | 1720 |
|
|
2024
Q4 | $3.87M | Buy |
69,826
+10,991
| +19% | +$609K | ﹤0.01% | 1735 |
|
|
2024
Q3 | $1.94M | Buy |
58,835
+5,709
| +11% | +$188K | ﹤0.01% | 2055 |
|
|
2024
Q2 | $1.44M | Buy |
53,126
+30,406
| +134% | +$826K | ﹤0.01% | 2169 |
|
|
2024
Q1 | $826K | Buy |
+22,720
| New | +$826K | ﹤0.01% | 2101 |
|